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Abstract
Background: Cell growth underlies many key cellular and developmental processes, yet a
limited number of studies have been carried out on cell-growth regulation. Comprehensive
studies at the transcriptional, proteomic and metabolic levels under defined controlled
conditions are currently lacking.
Results: Metabolic control analysis is being exploited in a systems biology study of the
eukaryotic cell. Using chemostat culture, we have measured the impact of changes in flux
(growth rate) on the transcriptome, proteome, endometabolome and exometabolome of the
yeast Saccharomyces cerevisiae. Each functional genomic level shows clear growth-rate-
associated trends and discriminates between carbon-sufficient and carbon-limited conditions.
Genes consistently and significantly upregulated with increasing growth rate are frequently
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Background
Metabolic control analysis [1] is a conceptual and mathe-
matical formalism that models the relative contributions of
individual effectors in a pathway to both the flux through
the pathway and the concentrations of intermediates within
it. To exploit metabolic control analysis in an initial systems
biology analysis of the eukaryotic cell, two categories of
experiments are required. In category 1, flux is changed and
the impact on the levels of the direct and indirect products
of gene action is measured. In category 2, the levels of indi-
vidual gene products are altered, and the impact on the flux
is measured. In this category 1 study, we have measured the
impact of changing the flux on the transcriptome, pro-
teome, and metabolome of Saccharomyces cerevisiae. In this
whole-cell analysis, flux equates to growth rate.
Cell growth (the increase in cell mass through macromolec-
ular synthesis) requires the synthesis of cellular components
in precise, stoichiometric quantities, and must be subject to
tight coordinate control [2-6]. Cell growth underpins many
critical cellular and developmental processes, yet compre-
hensive studies on growth rate and its control have lagged
behind those on cell-cycle progression [7,8], cell prolifera-
tion [4,6] and coupling between cell growth and division
[9,10]. A limited number of studies in batch (flask) cultures
in complex media have been reported for the important
model eukaryote Saccharomyces cerevisiae. These showed that
the coordinate expression of ribosomal protein genes with
growth rate appeared regulated almost entirely at the tran-
scriptional level [11-13]. However, these batch studies
could not separate growth rate from nutritional effects [14].
Chemostat cultures in defined media constitute an adequate
alternative, allowing the study of physiological patterns
under controlled environmental conditions [14-17]. How-
ever, the majority of chemostat studies have mainly focused
on the characterization of environmental responses at a
single growth rate [18-20], and so the mechanisms involved
in the regulation of growth-rate-related genes are still poorly
understood. Previous investigations have been confined to
the RNA level; however, an increasing number of studies
demonstrate the importance of post-transcriptional (trans-
lational and post-translational) mechanisms [21-24]. This
evidence for control being exerted at multiple levels empha-
sizes the need to extend metabolic control analysis to
include the concept of modular control [25].
Comprehensive high-throughput analyses at the levels of
mRNAs, proteins, and metabolites, and studies on gene
expression patterns are required for systems biology studies
of cell growth [4,26-29]. Although such comprehensive data
sets are lacking, many studies have pointed to a central role
for the target-of-rapamycin (TOR) signal transduction
pathway in growth control. TOR is a serine/threonine kinase
that has been conserved from yeasts to mammals; it inte-
grates signals from nutrients or growth factors to regulate cell
growth and cell-cycle progression coordinately [3,30-33].
We have studied the control of the yeast transcriptome, pro-
teome, and metabolome in a manner that allows the sepa-
ration of growth-rate effects from nutritional effects, and
have paid particular attention to the role of the rapamycin-
sensitive TOR complex 1 (TORC1) [32] in mediating
growth-rate control. Both the concepts and the data gener-
ated by these experiments should provide a useful founda-
tion for the construction of dynamic models of the yeast cell
in systems biology [26-28].
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essential and encode evolutionarily conserved proteins of known function that participate in
many protein-protein interactions. In contrast, more unknown, and fewer essential, genes are
downregulated with increasing growth rate; their protein products rarely interact with one
another. A large proportion of yeast genes under positive growth-rate control share
orthologs with other eukaryotes, including humans. Significantly, transcription of genes
encoding components of the TOR complex (a major controller of eukaryotic cell growth) is
not subject to growth-rate regulation. Moreover, integrative studies reveal the extent and
importance of post-transcriptional control, patterns of control of metabolic fluxes at the level
of enzyme synthesis, and the relevance of specific enzymatic reactions in the control of
metabolic fluxes during cell growth.
Conclusions: This work constitutes a first comprehensive systems biology study on growth-
rate control in the eukaryotic cell. The results have direct implications for advanced studies
on cell growth, in vivo regulation of metabolic fluxes for comprehensive metabolic engineering,
and for the design of genome-scale systems biology models of the eukaryotic cell.
Results and discussion
Growth-rate effects revealed at all ‘omic’ levels
We wished to study the impact of growth rate on the total
complement of mRNA molecules, proteins, and metabo-
lites in S. cerevisiae, independent of any nutritional or other
physiological effects. To achieve this, we carried out our
analyses on yeast grown in steady-state chemostat culture
under four different nutrient limitations (glucose, ammo-
nium, phosphate, and sulfate) at three different dilution
(that is, growth) rates (D = µ = 0.07, 0.1, and 0.2/hour,
equivalent to population doubling times (Td) of 10 hours,
7 hours, and 3.5 hours, respectively; µ = specific growth
rate defined as grams of biomass generated per gram of
biomass present per unit time). We then looked for
changes that correlated with growth rate under all four
nutrient-limiting conditions, using principal components
analysis (PCA; see Materials and methods). Trends that
appear in all four nutrient-limited series, including carbon-
limited cultures with equivalent glucose concentrations,
cannot be attributed to variations in residual substrate
concentrations (for example, different levels of glucose
repression). Instead, they must be due to intrinsic growth-
rate-related processes.
Gene expression at the mRNA level was investigated by tran-
scriptome analysis using Affymetrix hybridization arrays.
Proteomic studies were performed using isotope tags for
multiplexed relative and absolute quantification (iTRAQ)
[34,35]. In this case, the four tags and labeling schema
applied (see Materials and methods) allowed us to test and
compare the proteomes of cells grown at µ = 0.1/hour (Td =
7 hours) with those of cells grown at µ = 0.2/hour (Td =
3.5 hours) for all four nutrient limitations. We were able to
detect and quantify a significant proportion of the yeast
proteome (around 700 proteins per nutrient-limiting condi-
tion; 1,358 proteins in total; see Materials and methods).
For the metabolome, which is the closest genomic level to
the cell’s phenotype [36,37], gas chromatography coupled
to time-of-flight mass spectrometry (GC/TOF-MS) was used
to analyze the complement of intracellular and extracellular
metabolites, that is, the endo- and the exometabolomes
[38,39].
Principal components analyses (PCA) of transcriptome,
proteome, and endo- and exometabolome data showed
clear growth-rate-associated trends for all omic levels
(Figure 1). In the case of the endo- and exometabolomes,
these trends are clearly revealed after independent analysis
of the carbon-limited and carbon-sufficient datasets (see
Figure 1d,f). This is because, in contrast to all other nutri-
ent-limited steady states, the endo- and exometabolomic
profiles from cells in glucose-limited steady-state cultures
showed no clear growth-rate trend. We infer from this that
yeast cells are well-adapted to growth under carbon-limited
conditions and are able to adjust the individual fluxes
through their metabolic network to regulate overflow
metabolism whatever overall flux is imposed by the external
supply of carbon substrate. This result is congruent with our
data from category 2 experiments (D. Delneri and S.G.O.,
unpublished work) in which we have examined the effect
that reducing the copy number of individual genes in
diploid cells has on flux by performing competition experi-
ments, in chemostat cultures, between yeast strains het-
erozygous for individual gene deletions.
For all three levels of ‘omic analysis, the data show a clear
distinction between carbon-limited and carbon-sufficient
cells (Figure 1). Once the data from the carbon-limited
steady states have been excluded, both the endometa-
bolome and the exometabolome data from all three carbon-
sufficient cultures show a clear and consistent growth-rate
trend (compare Figure 1c,e with d,f). In addition, for the
endometabolome data, the second principal component
separates the ammonium-limited cells from those grown
under phosphate and sulfate limitation (Figure 1d).
Figure 1a shows that the transcriptome data from nitrogen-
limited cells at the lowest growth rate studied (0.07/hour)
do not obey the general growth-rate trend. Uniquely among
all the cultures that we analyzed, cells from these cultures
had a pseudohyphal, rather than a budding, growth pattern;
these data should allow us to define those genes whose
expression is specifically associated with filamentous
growth. We did not examine the proteome at µ = 0.07/hour
and so do not know whether this difference is reflected at
the protein level. However, the proteomic data from all
steady-state cultures at µ = 0.1/hour and 0.2/hour show the
same clear discrimination between carbon-limited and
carbon-sufficient cells and the same growth-rate-associated
trend as was found with the metabolome and transcriptome
data. The fact that all ‘omes’ studied display a growth-rate-
associated trend suggests a multilevel control underlying
global regulation of cell growth, and we now examine these
levels in some detail.
Growth-rate control at the transcriptional level
Hybridization-array technology was used to determine how
the levels of gene transcripts changed with both flux
(growth rate) and nutrient environment. While the tran-
scriptomes of cells grown under each of the four nutrient-
limiting conditions have their own characteristics (see
Additional data files 1 (Figures S1 and S2), 2 (Tables S1 and
S2), and 3), there is a common qualitative and quantitative
response to increasing growth rate that is independent of
the specific nutrient limitation (see Figure 1a, and Addi-
tional data file 1 (Figures S3 and S4)).
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Figure 1
Principal components analyses (PCA) of steady-state chemostat cultures. The x and y axes represent the two main principal components (PC1,
PC2), the groups responsible for the majority of the variance in each global dataset (see Materials and methods). PCA and growth-rate trends
(dashed lines) at the (a) transcriptome (mRNA) level and (b) proteome level. (c,e) PCA and trends at the (c) endometabolome and (e)
exometabolome level, respectively. (d,f) Same as (c) and (e) for carbon-sufficient chemostat series (N-, P- and S- limited series; see text for
explanation). Each symbol represents a culture condition, colored as follows: red, carbon (C) limitation; blue, nitrogen (N) limitation; yellow,
phosphate (P) limitation; green, sulfate (S) limitation. The symbol shape indicates the specific growth rate, µ, of the culture: ovals, µ = 0.07/h;
triangles, µ = 0.1/h; rectangles, µ = 0.2/h. The circle round the blue ovals includes chemostat series exhibiting pseudohyphal growth (see text). As a
test of reproducibility, for each nutrient-limiting condition, one of the three µ = 0.07/h exometabolome samples was analyzed in triplicate.
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We performed an analysis of covariance (ANCOVA) in
order to identify those genes whose transcription was signif-
icantly and consistently upregulated or downregulated with
growth rate in all four nutrient-limitation conditions
studied (see Additional data file 1 (Figure S3)). These genes
were ranked by estimates of false discovery rate (FDR), in
this case the q-value [40] of the ANCOVA model (obtained
from the p-value, after multiple testing correction; see Addi-
tional data file 4), which represents the relative significance
in the (condition-independent) change in gene expression
with growth rate. Taking these q-values, we applied a cut-off
of 5% (q = 0.05 [40]; see Materials and methods). This pro-
duced a set of 493 genes whose expression is significantly
upregulated with increasing growth rate (q < 0.05; see also
Additional data file 4), and 398 genes that exhibited signifi-
cant and concomitant downregulation with increasing
growth rate, independent of the culture conditions (see
Additional data files 1 (Figure S4) and 2 (Tables S3 and S4)).
Essential genes, that is, genes whose deletion results in a
failure to grow on rich glucose-containing medium [41,42],
are statistically overrepresented in the list of genes signifi-
cantly upregulated with growth rate (161 out of 493
(32.6%); the fraction of all yeast genes that are essential is
around 17%), whereas they are significantly underrepre-
sented in the downregulated list (22 out of 398 (5.5%,
again compared to 17%)). The proportion of essential open
reading frames (ORFs) in the downregulated set (5.5%) is
significantly different from the proportion of essential ORFs
that we find not to be subject to growth-rate control
(16.8%). In fact the fraction of essential ORFs in this non-
growth-regulated set is indistinguishable from the propor-
tion of all yeast ORFs that are essential to growth (16.6%).
Despite the fact that genes that are downregulated with
increasing growth rate are rarely essential on rich medium
[41,42], the central role of all growth-regulated genes in cell
growth is confirmed by independent studies on deletion
mutants. This applies to both the essential and the non-
essential genes in both the up- and downregulated sets
(Figure 2a). Thus, null mutations in many of the genes that we
have identified as growth-regulated have been reported to
either be lethal or produce a severe growth defect (84.0% in
the upregulated set; 64.6% in the downregulated set) [41,42]
(see Additional data file 2 (Tables S3 and S4)). In all, our
studies have revealed the importance of nonessential genes
whose expression is growth-rate regulated in determining
whether yeast can grow at normal rates. This applies to genes
whose expression is downregulated with increasing growth
rate, as well as those under positive growth-rate regulation.
From all these studies, a significant number of genes (891;
15% of the protein-encoding genes in the genome) have
their transcript levels determined by growth rate (Figure 2a).
While many of these genes (198, 22.2%) correspond to
ORFs of so far unknown function (Figure 2a; see also Addi-
tional data file 2 (Tables S3 and S4)), according to
Affymetrix (12 July 2006) and Gene Ontology (GO) anno-
tations [43], an examination of the functions determined by
the remainder is instructive. Using two different GO analysis
tools (GoMiner [44] and GenMAPP [45]; see Additional
data files 1 (Figures S5-S16) and 2 (Tables S5-S11)) we
showed that the 435 genes of known function that are
upregulated with growth rate (see Figure 2a and Additional
data files 1 (Figure S4) and 2 (Table S3)) include a signifi-
cant proportion whose products are involved in the biologi-
cal processes of translation initiation, ribosome biogenesis
and assembly, protein biosynthesis, RNA metabolism,
nucleobase, nucleoside, nucleotide and nucleic acid metab-
olism, nucleus import and export and proteasome function
(see Additional data files 1 (Figures S5 and S11) and 2
(Tables S3 and S5)). The corresponding analysis of GO mol-
ecular functions for the same gene set showed the following
to be overrepresented: translation initiation factor activity
and nucleic acid (RNA) binding, structural constituent of
ribosome activity, ligase activity forming aminoacyl-tRNAs
and DNA-directed RNA polymerase activity (see Additional
data files 1 (Figures S6 and S12) and 2 (Table S6)). At the
level of cellular components, GO studies indicated that the
most representative upregulated processes occur in a variety
of subcellular compartments (cytosol, exosome, and nucleus)
and complexes (for example, eukaryotic translation initiation
complexes, nucleolus, ribosome subunits, and the protea-
some core complex; see Additional data files 1 (Figures S7
and S13) and 2 (Table S7)). For a comprehensive analysis of
processes upregulated with increasing growth rate, see Addi-
tional data file 5.
GO analysis of the set of 258 genes of known function
whose transcription was significantly downregulated with
increasing growth rate (see Figure 2a and Additional data
files 1 (Figure S3) and 2 (Table S4)) shows that a high
proportion of these genes correspond to the following bio-
logical processes: response to external stimulus, cell com-
munication and signal transduction, autophagy, homeostasis,
response to stress, vesicle recycling within Golgi (see Addi-
tional data files 1 (Figures S8 and S14) and 2 (Table S9)).
The most overrepresented GO molecular function categories
for this gene set correspond to a variety of catalytic, signal
transduction, transcription regulator, and transport activi-
ties. These include receptor signaling protein activity,
protein kinases, phosphotransferase, oxidoreductase and
ATPase activity coupled to transmembrane movement of
ions, and phosphorylation mechanisms (see Additional
data files 1 (Figures S9 and S15) and 2 (Table S10)). At the
level of cellular component, downregulated processes occur
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at the level of the plasma membrane, the vacuole, and the
repairosome (see Additional data files 1 (Figures S10 and S16)
and 2 (Table S11)). Although essential genes are under-
represented in this list (22 out of 398; see Additional data
file 2 (Table S4) and the Saccharomyces Genome Database
[42]), the fact that 64.6% of the downregulated genes have
been reported to result in growth defects or inviability in
gene deletion studies (see Additional data file 2 (Table S4)
and [42]) points to a crucial role of these genes in growth-
related processes that has yet to be elucidated. All of the 22
essential genes in this set are of known function, but only
11 of them have been reported previously as being directly
related to cell growth and maintenance. For a comprehen-
sive analysis of the role of most relevant downregulated
processes regulating cell growth at the transcriptional level,
see Additional data file 5.
Genes that are downregulated with increasing growth rate
are probably involved in maximizing the efficient utiliza-
tion of cellular resources at each different growth rate and
culture condition, particularly when nutrients are scarce.
Our data indicate that this is a poorly understood aspect of
the cell’s economy since a significant number of these genes
(140/398; 35.2%) are of as-yet-undetermined function. This
is despite the fact that nutrient scarcity is likely to be a
common circumstance in the organism’s natural environ-
ment [46]. Among the genes of known function that are
upregulated at low growth rates are those involved in mobi-
lization and storage of available resources at the level of the
vacuole (see Additional data file 1 (Figure S20)). Another
interesting example of genes that are upregulated at low
growth rates are those involved in autophagy (see Addi-
tional data file 1 (Figure S21)). Autophagy is a major system
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Figure 2
Cell-growth regulation of gene expression at the transcriptional level. (a) Groups of genes significantly upregulated (main red block) and
downregulated (main green block) with growth rate irrespective of the nutrient-limiting condition, and their conservation in eukaryotes. The smaller
blocks to the right represent the percentages of conserved orthologous proteins in Homo sapiens alone and in five model eukaryotic organisms [52].
The number of non-annotated open reading frames (ORFs) in up- and downregulated lists (that is, ORFs/genes of unknown function Affymetrix
annotation 12 July 2006) is included. (b) Target-of-rapamycin (TOR) regulation at the transcriptional level. Genes upregulated and downregulated
with growth rate are indicated by red and green circles, respectively. Groups of genes whose transcription is significantly downregulated by
rapamycin treatment are indicated by the blue circle; those upregulated by the purple circle. Overlapping areas indicate groups of specific growth-
related genes whose expression is significantly affected by rapamycin at the transcriptional level.
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of bulk degradation of cellular components. It participates
in the coordinate degradation of cytoplasmic components,
including proteins, large complexes and organelles whose
turnover is important in the control of cell growth.
Autophagy mediates the shrinkage of the ribosome pool,
thus slowing cell growth when nutrients are limiting [47].
Autophagy in yeast has been reported to be a TOR-mediated
response to nutrient starvation [48], and we have demon-
strated previously the induction of autophagy genes in sta-
tionary phase [19]. Autophagy genes are well conserved
from yeast to mammals, suggesting that it is a fundamental
activity of eukaryotic cells, being implicated in processes
such as homeostasis, development and differentiation [47].
Other genes that are upregulated at low growth rates are
those encoding specific transcriptional repressors whose
action results in the activation of alternative routes for the
assimilation of substrates and/or as an adaptation to the
environment.
In all, the data on the downregulated genes present a picture
of the yeast cell at low growth rates activating pathways
involved in the response to external stimuli, maintenance of
homeostasis, vacuolar transport and storage, and autophagy;
the whole being directed towards a more efficient use of
scarce resources. Finally, we have found that genes that were
annotated previously as being involved in ‘response to stress’
[42,49,50] are upregulated at low growth rates. Moreover, we
have confirmed these findings at the proteome level (see pro-
teomic studies (Table 1)). This demonstrates that a large part
of what others have termed the ‘generalized stress response’
may more properly be viewed as a slow-growth response.
Cell-growth-related genes subjected to
transcriptional control encode a core protein
machinery conserved among all eukaryotes
A high percentage of the proteins encoded by the up- and
downregulated genes are highly conserved in a variety of
‘model’ eukaryotes (Ashbya gossypii, Caenorhabditis elegans,
Arabidopsis thaliana, Drosophila melanogaster and Homo
sapiens) [51,52], which points to the existence of an essen-
tially conserved ‘core’ protein machinery governing cell
growth in the Eukarya. Thus, 75% of the protein products of
yeast genes upregulated with growth rate have orthologs in
humans, whereas 52% of the downregulated set have human
orthologs (which is not significantly different to the figure
of 48% for all S. cerevisiae proteins [51]; see Figure 2a and
Additional data file 2 (Tables S3 and S4)). Many of these
proteins are built into complex machines [53]. Proteins
encoded by the upregulated genes participate in a large
number of interactions with each other (876 interactions as
compared with 287 expected by chance), whereas those
encoded by the downregulated genes rarely interact with
one another (89 compared with the 193 expected by chance;
see Additional data files 2 (Tables S12 and S13) and 4).
TOR control of cell growth at the transcriptional level
The TOR signal transduction pathway is a central controller
of the eukaryotic cell, sensing cellular environment and
linking nutrient assimilation with translation initiation and
ribosomal protein synthesis to control cell growth
[3,4,33,54-56]. Many genes responsible for central growth
processes (for example, translation initiation, ribosome bio-
genesis, autophagy, stability of biosynthetic components)
are regulated at the transcriptional level (see Additional data
file 2 (Tables S3 and S4)) and are under the direct or indirect
control of TOR [32,33] (see Additional data file 1 (Figure
S22)). The exact mechanisms by which the TOR pathway
controls these processes are not known, but appear to be
mediated (at least, in part) by GATA-type, zinc-finger and
forkhead transcription factors [32,33,57-60]. We decided to
test the generality of the hypothesis that TOR, more specifi-
cally the TOR signaling branch that mediates temporal
control of cell growth (TORC1) complex [32], is the major
regulator of yeast gene expression in response to nutrient
availability, and hence of growth rate [3,31-33]. To do this,
we examined the impact of rapamycin, a specific inhibitor of
the TORC1 complex [32], and widely used to elicit the TOR
control response [32,61], on the yeast transcriptome [14].
The results of this examination should be approached with
caution for two reasons. First, few inhibitors are completely
specific in their action and thus our analysis is likely to be
complicated by side-effects of rapamycin on processes other
than TOR action. Second, as the addition of the inhibitor
would necessarily disturb the steady state of a chemostat
culture, we performed this experiment in batch. We have
shown previously that the use of batch culture introduces a
number of confounding variables to transcriptome analyses
that are avoided by the use of chemostats [14,19]. Thus, it
may be predicted that the rapamycin-inhibition experiment
would show more genes affected than were found to be
subject to growth-rate control in our chemostat studies.
This, indeed, proved to be the case (Figure 2b). Remarkably,
the rapamycin and growth-rate data showed more than
70% of growth-rate-regulated genes to be members of the
TOR-responsive sets. We found 397 growth-rate upregulated
genes to be downregulated by rapamycin, and 249 genes
downregulated by growth rate were upregulated in response
to the drug. Thus, 646 growth-rate-regulated genes (72.5%)
appear to be specifically controlled by TOR (Figure 2b; see
also Additional data files 1 (Figure S23) and 2 (Tables S15
and S16)). Our studies are also in good agreement with pre-
vious transcriptional studies on the effect of rapamycin on
yeast cultures, showing a characteristic global response, with
translational initiation, aminoacyl-tRNA synthetases, RNA
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polymerases, ribosome biogenesis and proteasome subunits
among the most significantly affected biological processes
(see Figure 2b and Additional data file 2 (Tables S15-S17)
and [61,62]). These are key processes in which our sets of
growth-rate-regulated genes are involved
In our results, none of the genes specifying the components
of the TORC1 complex [32,63] appears significantly regu-
lated at the level of transcription (see Additional data file 1
(Figures S24 and S25)), in agreement with previously
reported studies (SGD; ORF expression connection studies
[42]). Evidence is accumulating that post-transcriptional
mechanisms play an important role in the global regulation
of cell growth [24,64,65] (see also the section on transla-
tional control, below). As an example, many genes reported
to be involved in control of cell size or coordination
between cell growth and division [9] do not appear regu-
lated at the transcriptional level (see Additional data files 2
(Tables S3 and S4) and 5), showing that it is important to
extend these studies to the proteomic level.
Proteomic signatures of growth-rate change
Most global gene-expression studies have been entirely at
the transcriptome level and often assume that changes in
transcript levels should correlate with changes at the protein
level. However, there is ample evidence that this is a danger-
ous assumption [21-24,65-69]. We extended our study to
the proteome level using iTRAQ [34,35], covering a signifi-
cant proportion of the yeast proteome (around 700 proteins
per nutrient-limiting condition; 1,358 in total; see Materials
and methods). For example, we examined the differences in
protein levels (proteomic signatures) between cells growing
at µ = 0.1/hour and those growing at 0.2/hour under carbon
limitation (Figure 3 and Additional data file 2 (Table S18)),
and found a number of proteins and biological processes to
be significantly up- and downregulated under these condi-
tions (Table 1 and Additional data file 2 (Tables S19 and
S20)). Remarkably, as with the transcriptome profiles, these
proteomic signatures appear to be characteristic for each
nutrient-limiting condition, but there is also a common
pattern that represents the proteomic response to a growth-
rate shift from µ = 0.1 to 0.2/hour (see Figure 3a and Addi-
tional data files 1 (Figure S26) and 2 (Tables S18 and S21)).
Relative changes in proteome levels of proteins participating
in relevant biological processes are shown in Figure 3b.
Again, in common with the transcriptome data, most of the
changes in protein levels lie in a range between a less than
twofold decrease and a less than twofold increase (Figure 3a
and Additional data file 1 (Figure S26)). Similar analyses
(that is, ANOVA) to those performed on the transcriptome
data can be applied to identify groups of proteins that are
consistently and significantly up- or downregulated with
growth rate (see Additional data file 4).
Among the groups of proteins whose levels appear consis-
tently up- or downregulated with growth irrespective of the
specific nutrient limitation (see Figure 3 and Additional
data files 1 (Figure S26) and 2 (Tables S22 and S23)) are
proteins of the translational machinery (for example, trans-
lation initiation and elongation factors, ribosomal proteins,
aminoacyl-tRNA synthetases), enzymes involved in methio-
nine and methyl cycle metabolism, and regulatory enzymes
of amino-acid and other relevant biosynthetic pathways.
Selected groups of proteins are marked in color in Figure 3a.
As a relevant example, proteomic studies reveal different
responses in the levels of the two S-adenosylmethionine
synthetases, Sam1p and Sam2p (see Figure 3a and Addi-
tional data file 1 (Figure S26)). This, and the fact that the
SAM2 gene was significantly upregulated at the transcrip-
tional level (Additional data file 2 (Table S3)), are in accor-
dance with previous reports [70].
Finally, nutrient-independent changes in levels of metabolic
enzymes (see Figure 3a; the most relevant are included in
Additional data file 2 (Table S24)) with growth rate will be
of particular importance for the elucidation of the yeast
cell’s strategies for the control of central metabolic fluxes
during cell growth, and for the identification of groups of
metabolic enzymes consistently up- and downregulated at
the protein level (for example, amino-acid biosynthetic
enzymes; Table 2). These studies have direct implications
for the design of new comprehensive metabolic engineering
strategies, and will be discussed in the section below on
metabolic control, where (for example) the role of the
Sam1p and Sam2p isoenzymes is considered.
Proteome-transcriptome correlations
Because our transcriptome and proteome data had been
obtained from the same samples of cells from chemostat
cultures in steady state at growth rates of both 0.1 and
0.2/hour, and as these data had been normalized and statis-
tically analyzed in the same way, we were able to make a
realistic determination of the congruence between the level
of any gene transcript and its cognate protein product(s).
Example results are presented in Figure 4 for the glucose-
limited steady states. Overall, the correlation coefficients (r)
for each nutrient-limiting condition (C, N, P and S limita-
tion) lie between 0.4 and 0.7, indicating only a moderate
global congruence between transcript and protein levels
(see Additional data file 6), in agreement with some previ-
ous studies [65-69,71]. The fact that mRNA changes do not
generally correlate with protein changes suggests a wide-
spread role for post-transcriptional mechanisms in the
control of yeast’s growth rate (see below). Most transcripts
show a relative change in their level, between both growth
rates of 0.1/hour and 0.2/hour, that is within a twofold
range up and down, and the same is true for their cognate
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Figure 3
Gene-expression signatures at the protein level. (a) The graph shows the pattern of relative changes (fold change) in protein levels with a shift in
growth rate (µ) from 0.1 to 0.2/h (doubling time, Td = 6.9 to 3.5 h) under conditions of carbon limitation (663 proteins in total). ORFs were sorted
by biological process [42]. i, Methionine biosynthesis; ii, protein biosynthesis; iii, ubiquitin-dependent protein catabolism. Red, upregulated protein
expression; green, downregulated. Selected groups of proteins whose levels are consistently upregulated or downregulated with growth
independently of culture condition are labeled in the appropriate color. (b) Box-plot of relative changes in protein expression from growth rate 0.1
to 0.2/h of proteins of representative biological processes (>10 proteins identified per process). 1, Cell wall organization and biogenesis; 2, endo-
plasmic reticulum (ER) to Golgi transport; 3, ergosterol biosynthesis; 4, glycolysis; 5, methionine biosynthesis and methionine metabolism; 6, protein
biosynthesis; 7, protein folding; 8, purine nucleotide, purine base and pyrimidine base biosynthesis; 9, regulation of transcription; 10, ubiquitin-
dependent protein catabolism. Open and solid dots indicate presence of outliers that lie more than 3 or 1.5 times the interquartile range, respectively.
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Table 2
Amino-acid biosynthetic enzymes with protein levels consistently up- and downregulated with growth rate under all nutrient-
limiting conditions
Enzymes 
Amino-acid biosynthetic pathway Upregulated Downregulated
Arginine Aco1p, Aco2p,Cpa1p, Cpa2p Arg1p, Arg8p
Homocysteine, cysteine, methionine, and sulfur compounds Ecm17p, Met10p, Met13p,Sam2p, Met6p, Ado1p Sam1p
Glutamine Gln1p
Leucine, isoleucine, valine Ilv3p, Leu1p
Lysine Aco1p, Aco2p, Lys2p, Lys4p
Aco1p, aconitase; Aco2p, putative aconitase isozyme; Ado1p; adenosine kinase; Arg1p, arginosuccinate synthetase; Arg8p, acetylornithine
aminotransferase; Cpa1p, small subunit of carbamoyl phosphate synthetase; Cpa2p, large subunit of carbamoyl phosphate synthetase; Ecm17p, sulfite
reductase beta subunit; Gln1p, glutamine synthetase; Ilv3p, dihydroxyacid dehydratase; Leu1p, isopropylmalate isomerase; Lys2p, alpha aminoadipate
reductase; Lys4p, homoaconitase; Met6p, methionine synthase; Met10p, sulfite reductase alpha subunit; Met13p, methylenetetrahydrofolate
reductase isozyme; Sam1p, S-adenosylmethionine synthetase isozyme; Sam2p, S-adenosylmethionine synthetase isozyme.
Table 1
Groups of relevant biological processes regulated at the protein-expression level
Biological process Proteins (examples) p-value (GO studies)
Upregulated 
Cellular biosynthesis (81) Ser3p, Cpa1p, Lia1p Rpl10p 1.1E-29
Amino-acid and derivative metabolism (33) Gln1p, Leu1p, Lys4p 2.6E-21
Translation (42) Rpl6ap, Mes1p, Sui3p, Fun12p 4.8E-13
Macromolecule biosynthesis (48) Mdh2p, Rpl3p, Mes1p, Ths1p 5.7E-12
tRNA aminoacylation (9) Mes1p, Cdc60p, Ded81p 9.7E-9
Ribosome biogenesis and assembly (22) Nug1p, Rpl30p, Nop58p, Yf3p 3.2E-7
Purine nucleotide metabolism (8) Ade17p, Ade1p, Hpt1p 3.8E-6
Sulfur metabolism (8) Ecm17p, Met10p, Trx2p, Sam2p 2.2E-5
Organic-acid biosynthesis (4) Ald6p,Fas1p, Fas2p 3.6E-4
Regulation of protein metabolism (6) Asc1p, Cap2p, Rpl30p 1.2E-3
rRNA processing (8) Nug1p, Has1p, Utp10p 1.8E-2
Downregulated 
Cellular carbohydrate metabolism (19) Gre2p, Tsl1p, Tps1p, Eno1p 2E-7
Coenzyme metabolism (14) Pan5p, Mdh3p, Npt1p 5.8E-7
Response to stress (27) Pol30p, Hsp104p, Rvs161p 9.8E-7
Response to stimulus (31) Lap3p, Akr1p, Ycf1p, Fet3p 1.1E-5
Cellular macromolecule catabolism (17) Skp1p, Pre3p, Rpn3p, Kar2p 2.3E-4
Vacuole organization and biogenesis (6) Sec17p, Tpm1p, Vtc2p, Vtc3p 3.6E-4
Transport (35) Pet9p, Sar1p, Fet3p, Hxt3p 1.1E-3
Cellular lipid metabolism (11) Ncp1p, Erg1p, Erg27p. Lem3p 7.7E-3
Homeostasis (7) Skp1p, Ahp1p, Vma5p, Zrt3p 2E-2
Groups of relevant biological processes regulated at the protein expression level from growth rates 0.1 to 0.2/h under carbon limitation are shown
here. Proteins significantly upregulated or downregulated with increasing growth rate (relative fold-changes greater than 20%, 141 proteins) from
iTRAQ studies were analyzed by GO studies (GO tool, SGD Term Finder [42]). Numbers of proteins obtained per biological process are included in
brackets. Full lists of results, including genes significantly regulated at the protein expression level, for each biological process are provided in
Additional data file 2 (Tables S19 and S20).
proteins. However, there are a number of transcript-protein
pairs that are significant outliers, cases in which changes in
transcript levels do not result in comparable changes at the
protein level (for example, ADH4/Adh4p and ADO1/Ado1p
in Figure 4); examples of these outliers are shown more
clearly in Figure 5, and are discussed in the following section.
Growth-rate-associated changes in translational
control efficiencies
A number of post-transcriptional mechanisms might be
involved in modulating the cellular concentration of a given
protein relative to that of the mRNA species that encodes it.
These include mRNA recruitment from the nucleus and p-
bodies, polyadenylation states, level of polysomal occu-
pancy per transcript, and rates of protein degradation
[21-24,72-74]. To encompass all of these mechanisms of
translational control and quantify their overall effect, we
define the effective ‘translational control efficiency’
(Trlc Effi) of a given messenger RNA in terms of its P/R ratio
[proteini]/[mRNAi] (see Materials and methods and Addi-
tional data file 7), and show that the ratio of relative change
in the level of a protein to the relative change in its cognate
mRNA (obtainable from proteome-transcriptome studies;
see above) is equal numerically to the ratio of relative
changes in translational control efficiencies between the two
conditions studied (see Materials and methods and Addi-
tional data file 7).
By this means, and on a genome-wide scale, we can quan-
tify the relative changes in the overall translational control
efficiencies of mRNA molecules corresponding to a shift
from µ = 0.1 to 0.2/hour (that is, a doubling in specific
growth rate). The results are presented in Figure 5 (for just
the carbon-limited steady state) and in Additional data
file 8. The pattern of changes suggests that the translational
control efficiencies of particular mRNAs are modulated
selectively in order to fine-tune protein activities and meta-
bolic fluxes of relevant biological processes during cell
growth (Figure 5a,b). The pattern of changes in translational
control efficiencies is dependent on the specific nutrient-
limiting condition, with most transcripts showing a less
than twofold change (up or down) in their translational
efficiencies, but a few undergo much larger relative changes
(Figure 5a, see also Additional data files 1 (Figure S27) and 8).
This metric of the relative change in translational control
efficiency allowed us to make a quantitative estimate of the
relative contribution of post-transcriptional control mecha-
nisms to a change in growth rate. For each nutrient-limiting
condition, more than 35% of all transcripts were found to
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Figure 4
Integration of proteome and transcriptome studies. Proteome-transcriptome correlations are determined by the relative changes in protein levels
versus relative changes in transcriptional levels from µ = 0.1 to 0.2/h under conditions of carbon limitation. (a) Log2 correlations with the most
relevant outliers (cases in which changes in transcript levels do not result in comparable changes at the protein level) named. (b) Correlations
between relative changes in natural values. The lines with y/x slope 0.5, 1 and 2 respectively allow to delimit groups of protein/transcript pairs that
are correlated (y/x ratio >1) and anti-correlated (y/x ratio <1), and their limits (majority of them with y/x ratios within 0.5 and 2; [0.5 < y/x ratio < 2]).
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Figure 5
Cell-growth regulation of gene expression at the translational level. Translational control. (a) Patterns of relative changes in translational control
efficiencies from growth rate (µ) 0.1 to 0.2/h, under conditions of carbon-limitation. ORFs sorted by biological process [42]. i, Methionine
biosynthesis; ii, protein biosynthesis; iii, ubiquitin-dependent protein catabolism. Selected groups of transcripts whose translational control efficiency
is consistently up- or downregulated with growth independently of culture condition are marked in bold. Red, upregulation; green, downregulation.
(b) Box-plot of relative changes in translational control efficiencies from growth rate (µ) 0.1 to 0.2/h of transcripts in representative biological
processes (>10 proteins identified per process). 1, Cell wall organization and biogenesis; 2, ER to Golgi transport; 3, ergosterol biosynthesis;
4, glycolysis; 5, methionine biosynthesis and methionine metabolism; 6, protein biosynthesis; 7, protein folding; 8, purine nucleotide, purine base and
pyrimidine base biosynthesis; 9, regulation of transcription; 10, ubiquitin-dependent protein catabolism. Open and solid dots indicate presence of
outliers that lie more than 3 or 1.5 times the interquartile (IQR) range, respectively.
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change their translational efficiency to a significant (greater
than 20%) extent. Further studies, including analysis of
post-translational modifications across the proteome (for
example, phosphorylation and glycosylation), will provide
a more complete picture of the role of post-transcriptional
control during cell growth.
From all these data, we were able to extract groups of tran-
scripts whose translational control efficiencies are consis-
tently up- or downregulated with growth rate, irrespective of
the limiting nutrient. Transcripts in this category include
those encoding components of the translational machinery,
enzymes subject to covalent or allosteric regulation that are
involved in amino acid and other biosynthetic pathways,
and regulatory proteasome subunits. Selected cases are
marked in bold in Figure 5a and summarized in Additional
data file 2 (Table S25). As an interesting example, the relative
level of the transcript of CPA1 (encoding the small subunit
of the multimeric enzyme carbamoyl phosphate synthetase
(CPSase) in the arginine biosynthetic pathway) does not
change with growth rate (see Additional data file 2 (Table
S3)), but the overall efficiency with which this mRNA is
translated goes up significantly with growth rate (see Figure
5a, and Additional data file 8). Although CPSase activity has
been found to be subject to regulation at the transcriptional,
translational and metabolic levels [75-78], under the specific
conditions tested (synthetic medium under nutrient-limited
conditions, with ammonium as sole nitrogen source), it
appears to be regulated mainly at the translational level.
Growth-rate control at the level of the metabolome
How are the metabolic fluxes characteristic of an increase
in the rate of biomass accumulation actually controlled?
To what extent are these fluxes regulated by gene expres-
sion (enzyme expression levels) or by metabolic regula-
tion? To answer these questions, the quantitative
proteomic data must be integrated with those on the
metabolome. This is, without doubt, the most difficult
challenge in data integration that exists in functional
genomics or systems biology. To a large extent, it is
because the metabolome, in contrast to the transcriptome
and the proteome, has no simple, direct connection to the
genome [79]. We have recently developed statistical
approaches with which to integrate transcriptome data
with those for a small number of key metabolites (for
example, glucose, ethanol, CO2) [80], but we have yet to
extend this to the entire metabolome. This is a field in
which many different strategies are likely to be required
and, indeed, are starting to be developed - for instance,
metabolic network topology [81].
In the current study, we used the ANOVA analysis applied to
the iTRAQ proteomic data to identify proteins whose levels
were consistently up- or down- regulated with growth rate
(see Figure 3 and Additional data file 2 (Tables S22-S24)).
This analysis highlighted two growth-related metabolic
processes: the coupling of carbon and nitrogen fluxes
towards the synthesis of amino acids, for example, gluta-
mine and arginine (Figure 6); and the flux of methionine
and S-adenosylmethionine (SAM through the methyl cycle
[82,83] (Figure 7).
Coupling of carbon and nitrogen fluxes towards amino-acid
biosynthesis
In a synthetic medium with ammonium as sole nitrogen
source, the cell must synthesize all its amino acids de novo.
This implies an efficient coupling of carbon and nitrogen
fluxes from 2-oxoglutarate, increasing metabolic fluxes
through glutamate dehydrogenase and glutamine syn-
thetase towards the synthesis of all necessary amino acids
(Figure 6) [84]. 2-Oxoglutarate, considered to be one of the
12 basic precursor metabolites [85], is primarily synthesized
in the mitochondrion through the tricarboxylic acid cycle
(TCA). In our studies, we found Aco1p (aconitase) and
Aco2p (a putative aconitase isoenzyme with 55% amino-
acid sequence identity to Aco1p [86]) to be the TCA cycle
enzymes that were most significantly upregulated at the
level of protein expression (see Figure 6 and Additional data
file 2 (Table S22)). This points to an increase in flux
towards cis-aconitate and isocitrate (note that Aco1p partici-
pates in two consecutive steps in the TCA cycle). At the same
time, our endometabolome studies showed that the steady-
state levels of citrate, the initial substrate for aconitase, fell
with increasing growth rate (see Additional data file 2
(Table S26)).
Significant upregulation at the level of protein expression
towards increasing TCA fluxes was also found at the level of
succinate dehydrogenase, the enzyme complex coupling
oxidation of succinate to the transfer of electrons to
ubiquinone. Both Sdh1p and Sdh2p (the flavoprotein and
iron-sulfur subunits of the succinate dehydrogenase
complex) were significantly upregulated with growth rate
(q = 0.051 and 0.046, respectively). Once again, meta-
bolome studies showed a decrease in the in vivo steady-state
levels of the corresponding substrate, succinate, at higher
growth rates (see Additional data file 2 (Table S26)).
Among the enzymes responsible for the supply of 2-oxo-
glutarate in the cytosol, Idp2p (NADP-isocitrate dehydroge-
nase) and Odc1p (one of two isoforms of the mitochondrial
2-oxoglutarate transporter [87]) were not detected in our
proteomic analyses and the transcriptional patterns of their
cognate genes were not in the growth-rate-regulated set
(q for IDP2 = 0.13; q for ODC1 = 0.32; no clear trends with
growth rate). However, ODC2, which encodes the other
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isoform of the mitochondrial transporter, Odc2p, is consis-
tently and significantly upregulated with growth rate at both
the mRNA (q = 0.05) and protein (q = 0.12) levels. This
demonstrates the importance of mitochondrial transport in
the regulation of amino acid biosynthesis and represents a
first example of the differential regulation of two enzyme
isoforms (with 61% amino-acid sequence identity) with
growth rate (see below).
In addition to increased levels of Odc2p, our proteomic
data also demonstrate that the levels of glutamine syn-
thetase (Gln1p) as well as the small and large carbamoyl-
phosphate synthase subunits (Cpa1p and Cpa2p) are
upregulated with growth rate (see Figure 3a and Additional
data files 1 (Figure S26) and 2 (Table S27)). These are
important regulatory enzymes whose expression and activ-
ity have been reported to be tightly regulated at the tran-
scriptional, translational, post-translational and metabolic
levels [75-78,84,88-90]. The endometabolome data showed
no significant growth-rate-associated change in the steady-
state 2-oxoglutarate and glutamine levels, with only gluta-
mate exhibiting a decrease in its intracellular level (see
Additional data file 2 (Table S26)). Glutamate is one of
several metabolites sensed by TOR, which regulates the
activity and localization of the Gat1p (Nil1p) transcription
factor, which (in turn) mediates nitrogen catabolite repres-
sion in response to intracellular glutamate (see Figure 6)
[91,92].
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Figure 6
Integration of proteome and metabolic control to show regulation of carbon and nitrogen metabolic fluxes at the protein (enzyme) level. Shown
here are the coupling of carbon and nitrogen fluxes at the level of glutamate dehydrogenase (Gdh1p, Gdh2p) and glutamine synthetase (Gln1p), the
regulation of arginine biosynthesis at the carbamoyl phosphate synthetase (Cpa1p, Cpa2p) level and amino-acid biosynthesis, and amino-acid sensing
by TOR. Selected proteins with levels consistently upregulated (red) with growth independently of culture conditions are shown. Enzymes
responsible for the cytosolic 2-oxoglutarate pool: Aco1p and Aco2p, aconitase and putative aconitase isoenzyme; Odc1p and Odc2p, mitochondrial
2-oxoglutarate transporters; Idp2p, NADP-specific isocitrate dehydrogenase. Enzyme subunits coupling the oxidation of succinate to the transfer of
electrons to ubiquinone: Sdh1p and Sdh2p, succinate dehydrogenase, flavoprotein, and iron-sulfur protein subunits, respectively. Metabolic diagram
from [42, 91, 92] and drawn using Cell Designer [136] and Adobe Illustrator [137].
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Metabolic fluxes towards methionine and S-adenosylmethionine
S-adenosylmethionine (AdoMet or SAM), the methyl donor
for the majority of methyltransferase reactions [93,94] is
one of the most connected metabolites in the cell, after ATP.
It participates in a myriad of biochemical processes in dif-
ferent subcellular compartments (for example, cytosol,
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Figure 7
Integration of proteome and metabolic control to show regulation of sulfur and C1 (folate) metabolic fluxes at the protein (enzyme) level. Selected
proteins with levels consistently upregulated (red) or downregulated (green) with growth independently of culture conditions are shown. Sulfur, C1
metabolism, methyl cycle, methionine and S-adenosylmethionine (SAM) fluxes towards methylation of proteins, rRNAs and tRNAs, and protein
biosynthesis are shown here. Metabolic pathways and enzymes are from [42,82,103-105] and the diagram is drawn with Cell Designer [136] and
Adobe Illustrator [137]. Reverse methionine biosynthetic pathways [83] have been omitted for clarity. Metabolite abbreviations: THF,
tetrahydrofolate; METTHF, 5,10-methylenetetrahydrofolate; MTHPTGLUT, 5-methyltetrahydropteroyltriglutamate (donor of the terminal methyl
group in methionine biosynthesis); GT, glutathione; CYS, cysteine; CT, cystathionine; OAHS, O-acetylhomoserine; HCYS, homocysteine; MET,
methionine; SAM, S-adenosylmethionine; SAH, S-adenosylhomocysteine; D-SAM, decarboxylated S-adenosylmethionine; MTA, methylthioadenosine.
Metabolic steps (genes/enzymes): Met10p, sulfite reductase alpha subunit; Ecm17p, sulfite reductase beta subunit; MET7, folylpolyglutamate
synthetase (Met7p not detected; the relevance of polyglutamylation in the C1 metabolism branch was demonstrated at the transcriptional level (see
text)); Met13p, methylenetetrahydrofolate reductase isozyme; Met6p, methionine synthase; Mes1p, methionyl-tRNA synthetase; Sam1p,
S-adenosylmethionine synthetase isozyme; Sam2p, S-adenosylmethionine synthetase isozyme. Sah1p, S-adenosyl-L-homocysteine hydrolase; Ado1p,
adenosine kinase.
SAM
Sam1p
Sam2p
SAH
Sah1p
HCYS
METMethyl
cycle
Mes1p
Met-tRNA TranslationProtein biosynthesis
Polyamines
D-SAM
MTA
Biotin
MTA
cycle
Methylations
Methyltransferases
ADP
Ado1pAMP
ATP
Adenosine
SO42-
S2−
OAHS
Sulfur uptake
CT
CYS
GT
Redox metabolism
Met6p
MTHPTGLUT
METTHF
Met13p
THF
C1 metabolism
Glutamate
Polyglutamylation
MET7
Ecm17p
Met10p
nucleus, and mitochondria) [82,83,95]. How is the synthe-
sis of this central metabolite regulated and its internal fluxes
appropriately distributed?
At the metabolic level, yeast cells have been reported to
contain at least two separate SAM pools, with different
turnover rates, a labile cytosolic pool and a more stable
organellar (mainly vacuolar) pool [96]. We detected SAM
(together with low levels of cystathionine, cysteine and glu-
tathione - this last confirming negligible oxidative stress) in
our steady-state endometabolome samples (see Additional
data file 2 (Table S28)), but we cannot determine how it is
partitioned between the organellar and cytosolic compart-
ments. Nonetheless, our results show that gross SAM levels
do change with growth rate in a manner that is specific for
each of the different nutrient limitations examined.
Saccharomyces cerevisiae contains two S-adenosylmethionine
synthetase genes, responsible for the synthesis of SAM from
methionine, SAM1 and SAM2. The protein products of these
two genes are 92% identical [70,82]. Sam1p is the most
abundant isoenzyme and is localized in the cytoplasm
[97,98]. It is a highly interconnected protein and interacts
with proteins involved in a number of central metabolic
processes (for example, multimeric enzymes in glycolysis/glu-
coneogenesis and amino acid biosynthetic pathways; Pfk1p,
Pfk2p, Gpm1p, His4p, Trp2p, Trp3p, and proteasome sub-
units; Rpn1p, Rpn2p), nuclear pore proteins (for example,
Kap95p, Kap104p, Kap123p, Crm1p, Mtr10p, Nup2p), mito-
chondrial proteins (for example, Mpm1p, Mis1p, Mdj1p),
vacuolar proteins and proteins involved in vacuolar protein
sorting (for example, Vps13p, Vps1p, Vth2p, Vma6p). These
interactions have been extracted from the BioGRID database
of curated interactions [99] and the paper by Gavin and
coworkers [100]. On the other hand, Sam2p has no clear sub-
cellular localization [97,98] and is rarely associated with
other proteins [99,100]. No specific functions have so far
been assigned to these two isoenzymes in S. cerevisiae [82].
We find that SAM2 mRNA levels are significantly upregulated
with growth rate (see Additional data file 2 (Table S3)),
whereas the SAM1 transcript shows no significant upregula-
tion with increasing growth rate, confirmed by quantitative
real-time PCR (QRT-PCR). More pertinently, our proteomic
studies under all four nutrient-limiting conditions show that
the increase in growth rate from µ = 0.1 to 0.2/hour entails an
increase in the levels of a number of enzymes (for example,
Ado1p, Met13p, Met6p, Sam2p) involved in methionine and
SAM biosynthesis, and these results have been confirmed by
two-dimensional difference gel electrophoresis [101,102]
(see Materials and methods). In contrast, the levels of Sam1p
actually fall with increasing growth rate (Figure 7, and Addi-
tional data files 1 (Figure S29) and 2 (Tables S23 and S25)).
Increased fluxes through C1 (folate) metabolism towards
synthesis of 5-methyltetrahydropteroyltriglutamate, the donor
of the terminal methyl group in methionine synthesis
[42,103,104] were demonstrated by significant upregula-
tion of MET7 (q for MET7 = 0.042), encoding folylpoly-
glutamate synthetase (FPGS), which is responsible for
polyglutamylation of folate coenzymes [103-105], and
upregulated levels of methylenetetrahydrofolate reductase,
Met13p (see Figure 7 and Additional data file 2 (Table S22)).
Here, it is noteworthy that S. cerevisiae cells possess only one
methionine synthetase, Met6p, which functions without
cobalamin as a cofactor [42,103,104]. These results show
the relevance of controlled fluxes of glutamate in methion-
ine and SAM synthesis and point to the existence of close
interrelations between the carbon, nitrogen and sulfur
central metabolic pathways. The complete picture is one
where an increase in growth rate involves the mobilization
of C1 and sulfur metabolism towards increasing synthesis
of SAM and proteins (see Figure 7).
We analyzed the growth-rate response of transcripts encod-
ing methyltransferases and found those responsible for the
methylation of rRNA (for example, NOP1, NOP2, SPB1 and
DIM1) and tRNA (for example, NCL1, TRM1, TRM3, TRM7,
TRM8) to be overrepresented in the group of genes whose
transcription is significantly upregulated with growth rate
(q < 0.09; from the ANCOVA analysis). Control of rRNA and
tRNA synthesis (including rRNA and tRNA methylation) is
closely tied to cell growth [106]. From reports in the litera-
ture, we have calculated that more than 2,000 methylation
events per second are required just for the de novo synthesis
of rRNA [107,108]. Thus, high growth rates will generate a
high demand for SAM simply to sustain the methylation of
rRNAs and tRNAs, let alone the requirements associated with
the methylation of the GpppN termini of capped mRNAs
[109]. Our data indicate that the increasing levels of Sam2p
are most likely to satisfy this demand at high growth rates,
thus associating Sam2p with the high-turnover pool of SAM.
In contrast, Sam1p may have the main responsibility for the
redistribution of SAM between the different subcellular
organelles. A definitive attribution of the division of respon-
sibility for the production of this key metabolite between the
two isoenzymes must await more advanced studies involving
selective labeling and in vivo imaging.
The above examples show that integration of transcrip-
tomic, proteomic, and metabolomic studies can provide
detailed information about cellular strategies to direct meta-
bolic fluxes toward the supply of intermediates required to
sustain cell growth. However, a key question remains unan-
swered: how is the control of metabolic flux shared between
regulation at the level of gene expression (that is, enzyme
expression levels) and regulation at the level of metabolism
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itself, where individual intermediates can alter enzyme
activity? In Figure 8, we show the impact of a change in
growth rate (from 0.1 to 0.2/hour, in carbon- and phos-
phate-limited chemostat cultures) on the relative levels of
the enzymes involved in the biosynthesis of leucine, an
amino acid that has been reported as an upstream regulator
of the TOR pathway [31].
These data show that, within a particular metabolic
pathway, some enzymatic steps may be selectively regulated
at the level of enzyme production (for example, Ilv3p,
Leu1p), whereas others exhibit negligible regulation at the
protein level (for example, Ilv5p). Our results support the
‘hierarchical’ control concept encompassed by regulation
analysis theory [110] that has been used previously to
explain the control of glycolysis in yeast [111,112]. What is
now required is some convenient approach that will permit
a global, systematic integration of metabolome data with
those of transcriptomics and proteomics, rather than the
case-by-case analysis that we have presented here.
The above examples show that integration of transcrip-
tomic, proteomic, and metabolomic studies can provide
detailed information on cellular strategies for control of
metabolic fluxes. They have revealed the existence of differ-
entially regulated isoenzymes, which make complementary
contributions to metabolic flux at different growth rates.
This integrative approach, and the information obtained
from it, opens the way for systems biology to exploit new
theories (such as regulation analysis theory [110]) that
derive from the concepts of metabolic control analysis.
They also suggest novel strategies for the comprehensive
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Figure 8
Multiple enzyme regulation in the metabolic control of the leucine biosynthetic pathway at the protein level. In vivo relative changes in enzyme levels
from µ = 0.1 to 0.2/h, under carbon- (C) and phosphate- (P) limiting conditions are indicated by the lengths of the gray and white bars next to each
enzyme. Their position under or above the baseline indicates downregulation or upregulation, respectively. Leucine biosynthesis diagram and
nomenclature from [42]; diagram drawn with Cell Designer [136] and Adobe Illustrator [137]. Enzymes consistently upregulated under both
conditions are marked in red. Metabolic steps (enzymes):  Ilv2p, acetolactate synthase; Ilv6p, regulatory subunit of acetolactate synthase; Ilv5p,
acetohydroxyacid reductoisomerase; Ilv3p, dihydroxyacid dehydratase; Leu4p, 2-isopropylmalate synthase (main isozyme); Leu9p, 2-isopropylmalate
synthase (minor isozyme); Leu1p, isopropylmalate isomerase; Leu2p, 3-isopropylmalate dehydrogenase; Bat1p, mitochondrial branched-chain amino-
acid aminotransferase; Bat2p, cytosolic branched-chain amino-acid aminotransferase.
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metabolic engineering of yeast, one of the great workhorses
of both ancient and modern biotechnology.
Conclusions
The principle of multilevel regulation in metabolic control
analysis has been explored in a systems biology study of the
eukaryotic cell. We have measured the impact of changes in
growth rate on the transcriptome, proteome, and endo- and
exometabolomes of the yeast S. cerevisiae. Each level shows
clear growth-rate-associated trends and also discriminates
between different nutrient-limiting conditions.
Characteristic signatures at the transcriptomic, proteomic,
and exo- and endo-metabolomic levels reveal groups of
growth-regulated genes, proteins and biological processes
controlled at different levels, with specific outliers character-
istic for each nutrient-limiting condition. A large proportion
of the growth-regulated yeast genes share protein orthologs
with other eukaryotes, including humans, which points to
the existence of an essentially conserved core protein
machinery governing cell growth in Eukarya. A high propor-
tion (72.5%) of these growth-regulated genes appear to be
targets for the TORC1 signaling pathway and participate in
a high number of protein-protein interactions.
Our studies emphasize the importance of TOR as a central
controller that integrates not only the sensing of nutritional
status, but also the response of all aspects of gene expres-
sion, including transcription, translation and protein stabil-
ity [3,31,32,55,113]. One relevant design rule [114]
elucidated by this study and data from our category 2 exper-
iments (D. Delneri and S.G.O., unpublished work) is that
major controllers of eukaryotic cell growth (such as TOR),
are not themselves subject to growth-rate control at the tran-
scriptional level. This appears to be a general trend in
biology. This, and the fact that genome-wide studies aimed to
extract all genes regulated under one condition fail to detect
genes known to make a significant phenotypic contribution
in the same condition [41,115,116], points to the need for
incorporation of new integrative strategies in order to identify
groups of genes controlled at different regulatory levels.
At the gene-expression level, comprehensive integration of
quantitative proteome and transcriptome data reveals the
widespread extent and importance of post-transcriptional
mechanisms in growth-rate control, specific for each nutri-
ent-limiting condition, and suggests that the translational
efficiencies of particular mRNAs are modulated selectively
in order to fine-tune protein activities and metabolic fluxes
during cell growth. Our studies open the way towards the
dissection of the contribution of transcriptional and transla-
tional control of gene expression in genome-wide studies.
Control of metabolic fluxes at the level of enzyme con-
centration is demonstrated by the integration of quantita-
tive proteomic and metabolome studies. The regulation
of metabolic flux appears as a dynamic process, involving
distributed control at the transcriptional, translational
and post-translational levels, and fine-tuning at the level
of the metabolites themselves [117,118]. This would
appear to be one of the sources of the intrinsic adaptabil-
ity and distributed robustness of the eukaryotic cell,
allowing it to adapt to short- and long-term environmen-
tal changes [119].
In all, the results reveal a multilevel, fine regulation of gene
expression and metabolic fluxes during cell growth. Our
results have direct implications in advanced studies on cell
growth, in vivo regulation of metabolic fluxes for compre-
hensive metabolic engineering, and the design of genome-
scale systems biology models of the eukaryotic cell.
Materials and methods
Yeast strain and experimental strategy
The diploid Saccharomyces cerevisiae strain FY1679
(MATa/MATα ura3-52/ura3-52 leu2-1/+trp1-63/+his3-D200/
+ho::kanMX4/ho::kanMX4 was used for all the experiments.
Conditions for chemostat cultivation in a mineral medium
under C, N, P and S nutrient limitation have been described
previously [14,120] and are given in Additional data file 4).
For the rapamycin study, a culture growing at mid-exponen-
tial phase was divided into two. Rapamycin (200 ng/ml)
was added to one half, and the drug’s solvent to the other,
as the control. Samples were taken at 0, 1, 2 and 4 h after
treatment (see Additional data file 4).
Transcriptional studies
Biomass was harvested and total RNA extracted as previously
described [14]. For growth-rate dependence studies, the
microarray experimental design consisted of four nutrient-
limiting conditions grown at three growth rates. These 12
conditions were analyzed in quadruplicate using Affymetrix
Yeast Genome S98 GeneChip oligonucleotide arrays
(Affymetrix, Santa Clara, CA). For the rapamycin study,
samples were analyzed in duplicate using YG_S98 arrays
(Affymetrix). Arrays that passed outlier data-quality assess-
ment using dChip software [121] were normalized with
RMAExpress [122]. For each probe set the coefficient of vari-
ation (CV) was calculated for each condition (%CV = (stan-
dard deviation/mean) × 100). The mean CV (variance in
transcriptional studies) was calculated, being in the range
between 2.4-3.9% in all cases. The data were submitted in
MIAME-compliant format to the ArrayExpress public reposi-
tory [123] under accession numbers E-MEXP-115 (growth-
rate studies) and E-MAXD-4 (rapamycin studies).
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Statistical analyses (PCA, t-tests, ANOVA/ANCOVA and
false-discovery rate estimation) to identify significantly reg-
ulated genes were performed with Matlab (MathWorks,
Natick, MA) [124], Q-value [40], GeneSpring (Agilent Tech-
nologies, Santa Clara, CA) [125] and maxdView software
(available from [126]); see Additional data file 4 for details.
Transcriptome results were validated by comparison of the
patterns of gene expression of genes from equivalent
chemostat experiments using an independent macroarray
technique [19] and, in addition, triplicate analyses of eight
genes were performed by QRT-PCR.
Proteome studies
Yeast were grown in chemostat culture as described above.
Cycloheximide (final concentration 100 µg/ml) was added
to 1-liter steady-state chemostat cultures. Cells (10 × 80 ml)
were harvested and centrifuged at 5,000 rpm for 5 minutes
at 4°C. The pellet was resuspended in 1 ml ice-cold double-
distilled water and transferred to a 1.5-ml microcentrifuge
tube. Cells were repelleted by centrifugation at 10,000 rpm,
the supernatant discarded, and the yeast pellet frozen in dry
ice and stored at -80°C.
Isotope tags for multiplexed relative and absolute quantification
(iTRAQ) of proteins
Protein samples were precipitated as follows. Chilled acetone
(1.8 ml) was added to a 300 µl sample. The tubes were
inverted three times and left at -20°C for 4 h. Precipitated
proteins were pelleted by a 10 minute centrifugation at
3,000 rpm, and resuspended in iTRAQ labeling buffer (8 M
urea, 2% Triton X100, 0.1% SDS and 25 mM triethyl
ammonium bicarbonate (TEAB) pH 8.5). Protein concen-
tration was determined using the detergent-compatible BCA
protein assay (Pierce, Rockford, IL).
Each sample (100 µg protein) was then reduced (4 mM
Tris(2-carboxyethyl) phosphine (TCEP), 20°C, 1 h) and cys-
teines blocked (8 mM methyl methanethiosulfonate (MMTS),
20°C 10 minutes). Samples were then diluted with 50 mM
TEAB (pH 8.5) such that the final urea concentration was
below 1 M, digested with trypsin (1:20) overnight at 37°C
(Promega, Madison, WI; 2.5 µg added at 0 and 1 h) and
lyophilized using a Savant AES2010 speed vacuum system.
Three separate iTRAQ labeling experiments were carried out
such that each sample corresponding to a nutrient limita-
tion and growth rate was labeled once. In each experiment
one of the iTRAQ tags was used to label a pooled sample
comprising equal amounts of each sample analyzed within
the experiment (see Additional data file 1 (Figure S28) for
the iTRAQ labeling scheme). Each lyophilized sample was
resuspended in 100 µl labeling buffer (0.25 M TEAB, 75%
ethanol), added to one unit of the corresponding iTRAQ
reagent and incubated for 1 h at 20°C. Residual reagent was
quenched by adding 100 µl water and incubating for a
further 15 minutes at 20°C. The samples belonging to the
iTRAQ comparisons were then pooled (pooled standard)
and lyophilized.
Cation exchange chromatography
Cation exchange fractionation of the iTRAQ samples was
carried out on a BioLC HPLC system (Dionex, Sunnyvale,
CA) using a polysulphoethyl A column (PolyLC, Columbia,
MD; 2.1 × 200 mm, 5 µm, 300 Å). The three lyophilized
iTRAQ-labeled pools were resuspended in 6 ml 20% vol/vol
acetonitrile (ACN), 10 mM KH2PO4-H3PO4 pH 2.7, loaded
and washed isocratically for 60 minutes at a flow rate of
200 µl/minute to remove the urea, detergents, and excess
reagents. Peptides were eluted using a linear gradient of 30-
125 mM KCl (20% vol/vol ACN, 10 mM KH2PO4-H3PO4
pH 2.7) over 70 minutes at a flow rate of 200 µl/minute.
Fractions were collected at 2-minute intervals, lyophilized
and resuspended in 70 µl 2% ACN, 0.1% trifluoroacetic
acid. Fractions 13-36 (collected between 65 mM and
105 mM KCl) from each iTRAQ experiment (72 fractions in
total) were analyzed by liquid chromatography followed by
tandem mass spectrometry (LC-MS/MS).
LC-MS/MS analysis
Peptides were separated and analyzed using an Ultimate
Plus nano-LC system (Dionex) coupled to a QSTAR XL
quadrupole TOF hybrid mass spectrometer (Applied Biosys-
tems, Foster City, CA). Samples (60 µl) were loaded onto an
Acclaim PA C16 pre-column (5 mm × 300 µm internal
diameter, Dionex) at 20 µl/minute and washed with 0.1%
formic acid (FA; also at 20 µl/minute) for 25 minutes to
desalt the samples. Peptides were then eluted onto a
PepMap C18 analytical column (15 cm × 75 µm internal
diameter, Dionex) at 150 nl/minute and separated using a
165 minute gradient of 5-32% ACN (0.1% FA). The QSTAR
XL was operated in information-dependent acquisition
(IDA) mode, in which a 1 second TOF-MS scan from 400-
1,600 m/z was performed, followed by 3 second product
ion scans from 100-1,580 m/z on the two most intense
doubly (2+) or triply (3+) charged ions.
MS data analysis and protein quantification
Mass spectrometry data files were processed using the
wiff2DTA software to generate centroided and uncentroided
peak lists [127]. Mascot version 2.0.01 (Matrix Science,
London, UK) was used to search centroided peak lists
against the Saccharomyces Genome Database protein data-
base (latest release). The following modifications were used:
fixed, iTRAQ (K), iTRAQ (N-term), MMTS (C); variable, oxi-
dation (M), iTRAQ (Y). The MS tolerance was 0.2 Da and
the MS/MS tolerance 0.5 Da. Each peak list was also
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searched against a reversed version of the database in order
to determine the false identification rate. Mascot peptide
score thresholds of 29 for all three experiments resulted in
false identification rates of less than 1% for proteins with at
least two peptides. iTRAQ reporter ion ratios were calcu-
lated from the uncentroided peak lists using i-Tracker
[35,128]. Normalized reporter ion areas were calculated as
follows: normalized area A = area A/(area A + area B + area
C + area D).
The Genome Annotating Proteomic Pipeline (GAPP) system
[129] was used to parse peptide identification and scoring
information from the Mascot output files and link these to
the quantification data in a relational database (MySQL
version 4.0, MySQL, Uppsala, Sweden). Peptides were quan-
tified if at least three of the four reporter ion peaks were
above a threshold of 15 counts and if they had a Mascot
score of at least 20. In addition, only peptides that were
unique to a single identified protein were quantified. After
application of this strategy, we were able to quantify a sig-
nificant proportion of the yeast proteome (around 700 pro-
teins per nutrient-limiting condition; 584 common to all
nutrient-limiting conditions; 1,358 unique proteins in
total). The global coefficient of variance of the proteomics
data was calculated using replicate pools and never
exceeded 13%. Proteomics (iTRAQ) results were validated
by two-dimensional difference gel electrophoresis [101,102],
confirming clear growth-rate trends at the global level (by
PCA) and consistent trends in patterns of expression of rep-
resentative relevant proteins (for example, Aco1p, Cpa2p,
Rpl5p, Met6p, Sam2p, Ado1p) (data not shown). Proteomic
data are in the process of being submitted to the PRIDE pro-
teomics repository [130].
Metabolome studies
Sampling, quenching, and efficient extraction for endo-
and exometabolome analyses of hundreds of intra- and
extracellular metabolites, including the main glycolytic
intermediates, nucleotides, pyridine nucleotides, and
organic acids (for example, pyruvate, citrate, and succinate)
were carried out as described previously [131]. Direct
quenching of the culture was performed by fast sampling
of a volume of culture equivalent to 30 mg dry weight
[131]; extracts and culture supernatants were stored at -
80°C. Samples were prepared for MS immediately before
the analysis was carried out.
GC/TOF-MS analysis
Two different sample types were analyzed, endometa-
bolome and exometabolome. Endometabolome samples
(typically 200 µl) were spiked with 4 µl internal standard
solution (2.22 mg/ml [2H2]malonic acid, 1.92 mg/ml
[2H5]glycine and 0.61 mg/ml [13C6]glucose dissolved in
water) and lyophilized using a Speedvac concentrator
vacuum system SPD111V connected to a Micromodulyo
Freeze Dryer (ThermoLife Sciences, Basingstoke, UK).
Exometabolome samples (1,000 µl) were spiked with 20 µl
internal standard solution and lyophilized as previously
described. Dried samples were derivatized as follows; 100 µl
of 20 mg/ml O-methylhydroxylamine solution was added
and heated at 40°C for 90 minutes followed by addition of
100 µl N-acetyl-N-(trimethylsilyl)-trifluoroacetamide and
heating at 40°C for 120 minutes. The final solution was
spiked with 20 µl retention index solution (0.6 mg/ml
n-decane, n-dodecane, n-pentadecane, n-nonadecane, n-doco-
sane dissolved in hexane).
All samples were analyzed on an Agilent 6890 gas chro-
matograph coupled to a LECO Pegasus III time-of-flight
mass spectrometer (LECO, St Joseph, MI) using the manu-
facturer’s software (ChromaTOF version 2.12) and a DB-50
GC column (Supelco, Gillingham, UK; 30 m × 0.25 mm ×
0.25 µm film thickness). The instrument conditions are
detailed in Additional data file 2 (Table S30). In the Chro-
maTOF software the S/N threshold was set at 10, baseline
offset at 1.0, data points for averaging at 7, and peak width
at 2.5. The TOF mass spectrometer can collect spectra at up
to 500 Hz and uses sophisticated but proprietary deconvo-
lution software to discriminate overlapping peaks on the
basis of their mass spectra. Initial processing of raw data was
undertaken using LECO ChromaTOF v2.12 software to con-
struct a data matrix (metabolite peak versus sample number)
using response ratios (peak area metabolite/peak area
[2H2]malonic acid) to calculate the relative amount of each
metabolite in each sample. For each metabolite peak for
each set of three biological replicates, the CV was calculated
as follows: %CV = (standard deviation/mean) × 100. The
mean CV for replicate analytical analyses (n = 3) was 24.6%
for all analyses undertaken, with 62% of these analyses
having a CV less than 20% and 38.04% having one less
than 10%. Although this shows precision to be less robust
than for targeted analyses, this is appropriate in metabolic
profiling, where many hundreds of metabolites are detected
in short analysis times.
Metabolite peaks were initially identified by searches on a
commercially available mass spectral library [NIST/EPA/
NIH (02)] (US National Institute of Standards and Technol-
ogy, the Environmental Protection Agency and the National
Institutes of Health; 2002) and libraries prepared by one of
us (W.B.D.). For a peak to be identified required a similarity
and reverse match score of greater than 700. Metabolite
identification was confirmed by the analysis of pure chemi-
cal standards in identical conditions to the sample analysis.
Identification was confirmed if the retention time (±5 s)
and mass spectra (similarity and reverse matches greater
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than 750) of metabolite peak in sample and standard were
equivalent. A list of profiled metabolites will be available
on request at the Manchester Centre for Integrative Systems
Biology website [132] after all metabolomic data are struc-
tured and annotated in a machine-usable form for efficient
data management (MeMo [133]) towards the implementa-
tion of a standard metabolomics framework [134].
Analysis of GC/MS raw data and metabolite levels
Within a GC/MS-based data matrix composed of response
ratios (peak area-metabolite/peak area-internal standard),
zero (or not detected) values can be obtained for any given
metabolite peak caused by either of the following reasons:
the metabolite is not present or is present at a concentration
below the limit of detection; or the metabolite cannot be
resolved from others in the chromatograph by the deconvo-
lution software. In these cases, the following procedure was
used to improve data structure for further univariate analy-
sis techniques. If two of three replicates were zero values
and the third replicate was a non-zero value, the third (non-
zero) replicate was replaced with zero. If two of three repli-
cates were non-zero values and the third replicate was a zero
value, the zero value for the third replicate was replaced
with the mean of the other two replicates.
Determination of relative changes in translational control efficiencies
To encompass all mechanisms involved in translational
control and to quantify its global effect, we define the trans-
lational control efficiency of each mRNAi (Trlc Effi) as the
effective translation of each transcript into protein (encom-
passing synthesis and degradation processes; net P/R ratio
(protein/mRNA) as follows:
Trlc Effi = ([Proteini]/([mRNAi]) (see also Additional data file 7).
From protein-transcriptome correlation studies we can
define the ratio of relative changes in protein versus tran-
script levels (ratio[( / )p/( / ) tr]) as:
Ratio [( / )p/( / )tr]i =
([Proteini]2/[Proteini]1)/([mRNAi]2/[mRNAi]1) (1)
Thus, as an example, when applied to relative changes
between two growth rates, for example, 0.2 versus 0.1/h:
Ratio[( / )p/( / )tr]i = 
[(Proteini 0.2/Proteini 0.1)/(Transcripti 0.2/Transcripti 0.1)]i =
([Proteini] 0.2/[Proteini] 0.1)/([mRNAi] 0.2/[mRNAi] 0.1)
From here, as Equation (1) can be rearranged as:
Ratio[( / )p/( / )tr]i =
([Proteini]2/([mRNAi]2)/([Proteini]1/[mRNAi]1) (2)
it follows that the Ratio[( / )p/( / )tr]i is numerically equal
to the ratio of translational control efficiencies i, from con-
dition 1 to condition 2:
Ratio[( / )p/( / )tr]i = (Trlc Eff)2/(Trlc Eff)1 = 
(Ratio Trlc Eff)i (3)
See also Additional data file 7.
Relative changes in translational control efficiencies are
obtained from microarray and proteomic studies. These
compare relative changes in gene expression of the same
individual transcript (or protein) between two different
growth rates. In these one-to-one comparisons, systematic
errors due to, for example, different labeling or hybridiza-
tion efficiencies are minimized. Moreover, we have sought
to reduce all sources of systematic error and a summary of
the strategies applied is included below. Despite all these
precautions, translational control efficiencies will always be
dependent on the accuracy of the techniques used to deter-
mine relative changes in gene expression. To evaluate these
data, one must take into account the CV obtained for each
independent technique used. These are provided above.
Minimization of systematic error
We sought to minimize sources of systematic error, first by
careful experimental design (see above) and the application
of the following strategies: use of steady-state chemostat cul-
tures ensuring carefully controlled environmental condi-
tions at each constant growth rate [14-17]; avoidance of
prolonged cultivation studies (that is, keeping to below 60
generations) to eliminate risks of strain variability and/or
mutational effects; fast sampling and growth-arrest methods
avoiding environmental disturbances for proper transcrip-
tome, proteome and metabolome analyses; for each omic
analysis, all samples were processed by the same specialist
researcher; careful analytical strategies and normalization
methods (see Additional data file 4).
Additional data files
The following additional data are available with this paper
online. Additional data file 1 contains additional figures.
Additional data file 2 contains additional tables. Additional
data file 3 contains the legends for the additional figures
and tables. Additional data file 4 contains supplementary
methods, including data analysis and processing for PCA,
transcriptome, proteome and metabolome data analyses
and integrative studies, statistical analyses on omic datasets,
GO studies, and analysis of protein-protein interactions.
Additional data file 5 includes additional studies on tran-
scriptional control of cell growth. Additional data file 6
contains proteome-transcriptome correlations. Additional
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data file 7 contains the main concepts of translational control
efficiency and translational control. Additional data file 8 con-
tains global patterns of relative changes in translational
control efficiencies. The whole article (with links to the addi-
tional documents) will also be available at the Manchester
Centre for Integrative Systems Biology website [132].
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